Pfizer Inc
Pfizer scraps daily weight loss pill after liver injury in one patient
Nikos Pekiaridis | Lightrocket | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in […]
Read More
Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more
Check out the companies making headlines in midday trading: Apple — Shares rebounded more than 5% on Wednesday after several days of selling pressure on the iPhone maker. Apple manufactures much of its products in China, which has been a key worry for investors in recent days in light of President Donald Trump’s 104% tariff […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more
Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he’s going to announce ” very shortly a major tariff on pharmaceuticals .” Pfizer and Merck shares each dropped more than 4%, while Eli Lilly shed […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Rafael Henrique | Lightrocket | Getty Images Shares of major vaccine makers dropped on Monday after a key U.S. health official resigned in protest of Health and Human Services Secretary Robert F. Kennedy Jr.’s views on immunization. The departure of Peter Marks, the Food and Drug Administration’s top vaccine regulator, has raised fresh fears about […]
Read More
Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to […]
Read More
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Chinese Vice Premier He Lifeng (R) shakes hands with US Senator Steve Daines before a meeting held in the Xinjiang Room at the Great Hall of the People in Beijing on March 22, 2025. Ng Han Guan | Afp | Getty Images China’s Vice Premier He Lifeng has reassured foreign business leaders that Beijing will […]
Read More
Pro-Trump senator meets Chinese Premier Li with U.S. executives
Chinese Premier Li Qiang (R) greets Pfizer CEO Albert Bourla from a delegation led by US Senator Steve Daines before a meeting held in the Fujian Room at the Great Hall of the People in Beijing on March 23, 2025. Ng Han Guan | Afp | Getty Images U.S. Republican Senator Steve Daines met Chinese […]
Read More
An all weather investment that’s consistently positive for those tired of the market roller coaster
The first member of the CNBC Pro All Weather Stock list is a surprisingly resilient exchange-trade fund that offers high dividend income to boot. The timing is right for this list in particular because of the precarious set-up of the stock market so far in 2025. We’ll be adding to it periodically as the year […]
Read More